Metabolomics of Right Ventricular Function in Pulmonary Hypertension

Read full text
Authors: Jonathan Chacon-Barahona, Samuel J. Chung, Jonah Garry, Robert P. Frantz, Franz Rischard, Paul M. Hassoun, Stephen C. Mathai, Catherine E. Simpson, Gerald Beck, Nicholas S. Hill, Jane A. Leopold, Aaron B. Waxman
+22 more Erika B. Rosenzweig, Barry A. Borlaug, MONICA MUKHERJEE, Rebecca Vanderpool, Miriam Jacob, Reena Mehra, M H Park, J Emanuel Finet, Samar Farha, Gabriele Grünig, Deborah Kwon, Suzy Comhair, Serpil Erzurum, John Barnard, Bo Hu, Christine Jellis, Alexandra Christin Racanelli, Jan Krumsiek, Evan L. Brittain, anna hemnes, Evelyn Horn, on behalf of the PVDOMICS Study Group
Cited by: 4
References: 45

Abstract

BACKGROUND: The metabolic mechanisms underlying right ventricular (RV) dysfunction are poorly understood, particularly outside of group 1 pulmonary hypertension (PH). We aimed to identify metabolites and pathways associated with RV systolic function and explored whether associations differed by pulmonary vascular resistance, PH group 1 status, and sex. METHODS: We analyzed data from the multicenter PVDOMICS (Pulmonary Vascular Disease Phenomics) cohort. RV systolic function metrics included fractional area change (echo), global longitudinal strain (echo), and ejection fraction (cardiac magnetic resonance). We used linear regression adjusted for age, sex, body mass index, and PH group to assess associations between metabolites and RV function. Pathway enrichment analyses were used to identify pathways significantly associated with RV function. Interaction terms were assessed to determine whether metabolite associations were modified by pulmonary vascular resistance, group 1 PH status, or sex. Least absolute shrinkage and selection operator regression was used to develop metabolite-based scores for RV function, and prognostic performance was assessed. RESULTS: There were 979 participants with plasma metabolomics and RV function data. Linear regression identified 170 metabolites that were significantly associated with all 3 RV metrics. Androgenic steroid, gamma-glutamyl amino acid, polyamine, vitamin A, fatty acid, and sterol pathways are most strongly associated with RV systolic function. Two metabolites interacted with group 1 PH status, and 6 interacted with pulmonary vascular resistance. Four androgenic steroids are associated more strongly with RV systolic function in women compared with men. Metabolite-based scores were prognostically equivalent to RV systolic function metrics and less accurate than REVEAL Lite 2 scores. CONCLUSIONS: We provide a blueprint of metabolites and metabolic pathways associated with RV systolic function across the spectrum of PH. Novel links to vitamin A and glutathione metabolites were observed. We detected few metabolites that associated with RV systolic function differentially by group 1 PH status or degree of pulmonary vascular resistance elevation. Androgenic steroids may associate more strongly with RV systolic function in women compared with men.

Fields of Study & Subjects

Pulmonary Hypertension Research and Treatments Eicosanoids and Hypertension Pharmacology Chronic Obstructive Pulmonary Disease (COPD) Research

Publication details

Journal / source
Circulation Research
Publisher
Ovid Technologies (Wolters Kluwer Health)
Volume
138
Issue
11
Pages
e327342–e327342
Publication date
15 April 2026
Language
EN